GATA-1 and PU.1 are two important hematopoietic transcription factors that mutually inhibit each other in progenitor cells to guide entrance into the erythroid or myeloid lineage, respectively. PU.1 controls its own expression during myelopoiesis by binding to the distal URE enhancer, whose deletion leads to acute myeloid leukemia (AML). We herein present evidence that GATA-1 binds to the PU.1 gene and inhibits its expression in human AML-erythroleukemias (EL). Furthermore, GATA-1 together with DNA methyl Transferase I (DNMT1) mediate repression of the PU.1 gene through the URE. Repression of the PU.1 gene involves both DNA methylation at the URE and its histone H3 lysine-K9 methylation and deacetylation as well as the H3K27 methylation at ...
PU.1 is a hematopoietic transcription factor that is required for the development of myeloid and B c...
The transcription factor PU.1 (Purine-rich DNA binding, SPI1) is a key regulator of hematopoiesis, w...
Transcriptional dysregulation is associated with haematological malignancy. Although mutations of th...
<div><p>GATA-1 and PU.1 are two important hematopoietic transcription factors that mutually inhibit ...
The GATA-1 transcription factor is capable of suppressing the myeloid gene expression program when e...
The GATA-1 transcription factor is ca-pable of suppressing the myeloid gene expression program when ...
Hematopoiesis is coordinated by a complex regulatory network of transcription factors among them PU....
Hematopoiesis is coordinated by a complex regulatory network of transcription factors among them PU....
In many hematopoietic malignancies such as lymphomas & leukemias, aberrant differentiation is t...
Hematopoiesis is a highly orchestrated process, in which a single hematopoietic stem cell (HSC) give...
Expression of the transcription factor GATA-1, which regulates several erythroid specific genes and ...
GATA-1 and PU.1 are transcription factors that control erythroid and myeloid development, respective...
Aberrant expression of PU.1 inhibits erythroid cell differentiation and contributes to the formation...
PU.1 is a key hematopoietic transcription factor. Knock-out of PU.1 in mouse is embryonic lethal due...
The transcription factor PU.1 is essential for myeloid development. Targeted disruption of an upstre...
PU.1 is a hematopoietic transcription factor that is required for the development of myeloid and B c...
The transcription factor PU.1 (Purine-rich DNA binding, SPI1) is a key regulator of hematopoiesis, w...
Transcriptional dysregulation is associated with haematological malignancy. Although mutations of th...
<div><p>GATA-1 and PU.1 are two important hematopoietic transcription factors that mutually inhibit ...
The GATA-1 transcription factor is capable of suppressing the myeloid gene expression program when e...
The GATA-1 transcription factor is ca-pable of suppressing the myeloid gene expression program when ...
Hematopoiesis is coordinated by a complex regulatory network of transcription factors among them PU....
Hematopoiesis is coordinated by a complex regulatory network of transcription factors among them PU....
In many hematopoietic malignancies such as lymphomas & leukemias, aberrant differentiation is t...
Hematopoiesis is a highly orchestrated process, in which a single hematopoietic stem cell (HSC) give...
Expression of the transcription factor GATA-1, which regulates several erythroid specific genes and ...
GATA-1 and PU.1 are transcription factors that control erythroid and myeloid development, respective...
Aberrant expression of PU.1 inhibits erythroid cell differentiation and contributes to the formation...
PU.1 is a key hematopoietic transcription factor. Knock-out of PU.1 in mouse is embryonic lethal due...
The transcription factor PU.1 is essential for myeloid development. Targeted disruption of an upstre...
PU.1 is a hematopoietic transcription factor that is required for the development of myeloid and B c...
The transcription factor PU.1 (Purine-rich DNA binding, SPI1) is a key regulator of hematopoiesis, w...
Transcriptional dysregulation is associated with haematological malignancy. Although mutations of th...